W. A. Dengler
- Co-authors
- Dietmar BergerR MertelsmannJohannes H. SchulteH. H. FiebigHeinz‐Herbert FiebigH.H. FiebigDieter MarméHeinz H. Fiebig
- Topics
- Monoclonal and Polyclonal Antibodies Research (3 papers)Toxin Mechanisms and Immunotoxins (3 papers)Cancer Research and Treatments (2 papers)
- Cited by
- BiotechnologyOncologyCancer Research
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
W. A. Dengler
10 papers receiving 513 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 254
- Oncology 173
- Cancer Research 85
- Organic Chemistry 80
- Pulmonary and Respiratory Medicine 66
Countries citing papers authored by W. A. Dengler
This map shows the geographic impact of W. A. Dengler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. A. Dengler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. A. Dengler more than expected).
Fields of papers citing papers by W. A. Dengler
This network shows the impact of papers produced by W. A. Dengler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. A. Dengler. The network helps show where W. A. Dengler may publish in the future.
Co-authorship network of co-authors of W. A. Dengler
This figure shows the co-authorship network connecting the top 25 collaborators of W. A. Dengler. A scholar is included among the top collaborators of W. A. Dengler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. A. Dengler. W. A. Dengler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 9 | |
| 3 | 8 | |
| 4 | Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells. | 112 |
| 5 | 219 | |
| 6 | 75 | |
| 7 | 39 | |
| 8 | 2 | |
| 9 | 45 | |
| 10 | 5 |
About W. A. Dengler
W. A. Dengler is a scholar working on Biotechnology, Cancer Research and Immunology, having authored 10 papers that have together received 532 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Biotechnology (57 citations), Oncology (173 citations) and Cancer Research (85 citations). W. A. Dengler has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Dietmar Berger, R Mertelsmann, Johannes H. Schulte, H. H. Fiebig, Heinz‐Herbert Fiebig, H.H. Fiebig, Dieter Marmé, Heinz H. Fiebig, Joseph G. Mayo and Edward A. Sausville. Their work appears in journals such as Annals of Oncology, International Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.